Portfolio company
Astute Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops in vitro diagnostic tests for hospitals and laboratories to identify sepsis, infectious diseases and other medical conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Presymptom Health
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
CytoVale
This medical diagnostics company develops the IntelliSep test to provide rapid sepsis detection for hospital emergency departments and health systems.
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
Levels Diagnostics
This company develops protein biomarker tests to help medical professionals diagnose infectious diseases and detect early-stage liver cancer from blood samples.
Abacus Diagnostica
This company develops molecular diagnostic systems for infectious disease testing, serving hospital laboratories and healthcare units.
GNOMX Corp
This company develops epigenetic diagnostic tests using artificial intelligence to identify infectious diseases and predict sepsis readmission risk for healthcare providers and clinicians.
